Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Body composition data should be interpreted cautiously due to the small subgroup analysis
However, it requires specific prior authorization to be submitted by your doctor
Hu Y, Liu J, Wang G, Xu Y
International journal of physiology, pathophysiology and pharmacology, 10(3), 132138 Santra, M., Zhang, Z
Documented research findings for Ipamorelin include: Dose-dependent, pulsatile GH release through selective GHS-R1a receptor activation Highly specific hormonal action minimal off-target stimulation of cortisol or prolactin pathways Synergistic GH pulse amplification when co-administered with GHRH analogues such as Modified GRF 1-29 Support for lean muscle anabolic signaling via downstream IGF-1 elevation Potential benefits for sleep architecture and recovery, mediated through GH-driven slow-wave sleep enhancement Preserved receptor sensitivity over extended research protocols low tachyphylaxis risk The Synergistic Science Behind This Tri-Peptide Blend The Fragment + Modified GRF 1-29 + Ipamorelin combination is built on a well-established principle in peptide pharmacology: simultaneous activation of the GHRH receptor and the ghrelin receptor produces GH pulse amplitudes significantly greater than either agonist achieves independently
US$ 28.49
US$ 22.77
US$ 24.63
US$ 20.64
